Form 4: Third Harmonic Bio Executive Julie Person Executes Stock Options Under 10b5-1 Plan

Julie Person, Chief Administrative Officer of Third Harmonic Bio, executed stock options and sold shares under a pre-arranged 10b5-1 trading plan.

Summary

• On April 4, 2024, Julie Person, Chief Administrative Officer of Third Harmonic Bio, exercised stock options to acquire 1,107 shares of common stock at a price of $4.20 per share.
• Simultaneously, Ms. Person sold 1,107 shares of common stock at $10.00 per share.
• These transactions were executed under a Rule 10b5-1 trading plan adopted on May 15, 2023.
• Following these transactions, Ms. Person directly owns 0 shares of Third Harmonic Bio common stock and 175,962 derivative securities.

Sentiment

Score: 5

Explanation: This is a routine filing related to pre-planned stock transactions. It doesn't necessarily indicate positive or negative sentiment about the company's future prospects.

Industry Context

Form 4 filings are routine disclosures of transactions by company insiders and are closely watched by investors for signals about management's view of the company's prospects. The use of a 10b5-1 plan indicates that these transactions were pre-planned.

Comparison to Industry Standards

• Executive compensation packages often include stock options as a way to align management's interests with those of shareholders.
• Rule 10b5-1 trading plans are a common tool used by executives to sell shares in a way that avoids accusations of insider trading.
• The vesting schedule of the options (25% initially, then quarterly installments) is a typical structure for employee equity grants.

Key Dates